User contributions for Karine
Jump to navigation
Jump to search
5 September 2023
- 15:5615:56, 5 September 2023 diff hist +77 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents
2 September 2023
- 20:4020:40, 2 September 2023 diff hist +480 m Neuroendocrine tumor →All lines of therapy Tag: Visual edit: Switched
- 20:3020:30, 2 September 2023 diff hist +836 Neuroendocrine tumor capecitabine & temozolomide for NET Tag: Visual edit: Switched
17 June 2021
- 23:4523:45, 17 June 2021 diff hist +158 m Antiemesis Selinexor added to antiemetic table
8 June 2021
- 21:0121:01, 8 June 2021 diff hist +64 m Antiemesis lurbinectedine emetic risk added
- 15:5815:58, 8 June 2021 diff hist +1 m Antiemesis formating
- 15:5815:58, 8 June 2021 diff hist +283 m Antiemesis formating, addting drug indexes
- 15:4715:47, 8 June 2021 diff hist +32 m Antiemesis formating antiemetic page
- 15:4415:44, 8 June 2021 diff hist +91 m Antiemesis formating antiemetic page
4 June 2021
- 22:1922:19, 4 June 2021 diff hist +743 m Carcinoma of unknown primary Carboplatin & Paclitaxel 2019 regimen for CUP
19 May 2021
- 21:0721:07, 19 May 2021 diff hist −2 m User:Karine Karine bio update Tag: Visual edit
- 20:4720:47, 19 May 2021 diff hist +751 m Urothelial carcinoma TROPHY-U-01 study evidence and reference
14 May 2021
- 21:0921:09, 14 May 2021 diff hist +1,298 Paroxysmal nocturnal hemoglobinuria iptacopan Lancet study regimen and reference
- 20:5520:55, 14 May 2021 diff hist +91 m Paroxysmal nocturnal hemoglobinuria investigational agents for PNH Tag: Visual edit
- 20:4820:48, 14 May 2021 diff hist +330 m Iptacopan (Fabhalta) Iptacopan drug index info continued
- 20:4320:43, 14 May 2021 diff hist +962 N Iptacopan (Fabhalta) Iptacopan drug index info
- 20:3020:30, 14 May 2021 diff hist +24 m Drug index iptacopan added to drug index
- 16:3316:33, 14 May 2021 diff hist +453 Non-small cell lung cancer Paz-Ares 2021 new regimen, chemo part
- 16:2416:24, 14 May 2021 diff hist +1,860 Non-small cell lung cancer Paz-Ares 2021 new regimen
- 14:5214:52, 14 May 2021 diff hist 0 m Prostate cancer formating
- 14:5014:50, 14 May 2021 diff hist +599 m Prostate cancer TITAN study final analysis reference
13 May 2021
- 19:5919:59, 13 May 2021 diff hist +459 Breast cancer, HER2-positive Tolaney 7 year update reference
12 May 2021
- 20:1620:16, 12 May 2021 diff hist +402 Urothelial carcinoma reference for RTOG 0524 Tag: Visual edit
- 20:0620:06, 12 May 2021 diff hist +589 m Urothelial carcinoma paclitaxel RT Pham 2014
8 May 2021
- 04:3804:38, 8 May 2021 diff hist +58 m Cold agglutinin disease →Sutimlimab monotherapy: formating Tag: Visual edit
- 04:2804:28, 8 May 2021 diff hist +215 Cold agglutinin disease Sutimlimab regimen NEJM 2021
- 04:1504:15, 8 May 2021 diff hist −198 m Cold agglutinin disease removed sutimlimab from investigational agents
- 04:1204:12, 8 May 2021 diff hist +449 Cold agglutinin disease Cold agglutinin disease new regimen with sutimlimab summary table
30 April 2021
- 21:1021:10, 30 April 2021 diff hist −201 m Antiemesis minor edit Tag: Visual edit
- 20:5220:52, 30 April 2021 diff hist +22 m Antiemesis atezo update and drug index Tag: Visual edit
- 20:4020:40, 30 April 2021 diff hist +24 m Antiemesis ado-trastuzumab and altretamine antiemetic updates Tag: Visual edit
- 20:2720:27, 30 April 2021 diff hist +14 m Antiemesis atezolizumab emetic potential update Tag: Visual edit
15 October 2020
- 20:3820:38, 15 October 2020 diff hist +222 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents Tag: Visual edit
- 20:3620:36, 15 October 2020 diff hist +110 m Antiemesis →Emetic risk of chemotherapy, immunotherapy, TKIs and other agents: Olaparib Tag: Visual edit
20 July 2020
- 23:3923:39, 20 July 2020 diff hist −6 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: Visual edit
- 23:3623:36, 20 July 2020 diff hist +16 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: JMC Tag: Visual edit
29 October 2019
- 22:0822:08, 29 October 2019 diff hist +253 N Talk:Small cell lung cancer Caspian study
6 September 2019
- 20:1520:15, 6 September 2019 diff hist +63 m Antiemesis Pixantrone and Pembrolizumab emetic MASCC risk Tag: Visual edit
- 20:1220:12, 6 September 2019 diff hist +61 m Antiemesis added new agents to main table and emetic risk by MASCC Tag: Visual edit
- 20:0120:01, 6 September 2019 diff hist +32 m Antiemesis added trabectedine to table with emetic potential by MASCC Tag: Visual edit
- 19:5419:54, 6 September 2019 diff hist 0 m Antiemesis MASCC 2019 updates Tag: Visual edit
- 19:5119:51, 6 September 2019 diff hist +16 m Antiemesis MASCC 2019 changes Tag: Visual edit
4 June 2019
- 02:5702:57, 4 June 2019 diff hist −207 m Antiemesis →Olanzapine (OLN) containing regimen: Deleted changes Tag: Visual edit
- 02:5502:55, 4 June 2019 diff hist +207 m Antiemesis Trying to start table formating for evidence Tag: Visual edit
- 02:3602:36, 4 June 2019 diff hist +67 m Hematology Oncology Fellowship Programs Directory →Hematology oncology fellowship programs: Jacobi medical center Tag: Visual edit
- 02:3102:31, 4 June 2019 diff hist +17 m Acute myeloid leukemia Formating Wei 2019 Tag: Visual edit
- 02:2702:27, 4 June 2019 diff hist +182 m Acute myeloid leukemia →Chemotherapy: AML loDAC venetoclax Wei 2019 update with venetoclax dose reduction Tag: Visual edit
19 May 2019
- 23:0823:08, 19 May 2019 diff hist +611 m Antiemesis Melphalan antiemesis with citation Tag: Visual edit
- 22:0022:00, 19 May 2019 diff hist −95 m Antiemesis BMT allo antiemesis Tag: Visual edit
- 18:1718:17, 19 May 2019 diff hist +94 m Antiemesis Allogeneic BMT conditioning Tag: Visual edit